Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

LXRX Lexicon Pharmaceuticals Inc

2,13

-0,10 (-4,48%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:46:41

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Jun 2024 bis Jul 2024

Click Here for more Lexicon Pharmaceuticals Charts.

Lexicon Pharmaceuticals (NASDAQ:LXRX)
Historical Stock Chart
Von Jul 2023 bis Jul 2024

Click Here for more Lexicon Pharmaceuticals Charts.

News Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Receives December 20, 2024 PDUFA Goal Date for Sotagliflozin Type 1 Diabetes NDA Resubmission
Dienstag 16 Juli 2024 (1 Tag vor) • GlobeNewswire Inc.

New Published Data Highlights Potential Cost-Savings of INPEFA® (sotagliflozin) for Heart Failure
Montag 15 Juli 2024 (2 Tage vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 8 Juli 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 8 Juli 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Montag 8 Juli 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 8 Juli 2024 (1 Woche vor) • Edgar (US Regulatory)

Lexicon Board of Directors Appoints Mike Exton, Ph.D. as New Chief Executive Officer and Director
Montag 8 Juli 2024 (1 Woche vor) • GlobeNewswire Inc.

Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes
Freitag 21 Juni 2024 (4 Wochen vor) • GlobeNewswire Inc.

Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association
Mittwoch 19 Juni 2024 (4 Wochen vor) • GlobeNewswire Inc.

Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology
Dienstag 18 Juni 2024 (4 Wochen vor) • GlobeNewswire Inc.

Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes Association
Freitag 14 Juni 2024 (1 Monat vor) • GlobeNewswire Inc.

Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024
Mittwoch 29 Mai 2024 (2 Monate vor) • GlobeNewswire Inc.

Weitere Lexicon Pharmaceuticals Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen